Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-12-038757
Filing Date
2012-07-20
Accepted
2012-07-20 17:04:14
Documents
1
Period of Report
2012-02-16

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 7514
  Complete submission text file 0001209191-12-038757.txt   8919
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 300 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 300 ROCKVILLE MD 20850 240-599-4500
Vanda Pharmaceuticals Inc. (Issuer) CIK: 0001347178 (see all company filings)

EIN.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 300 ROCKVILLE MD 20850
Business Address
Feeney John Joseph (Reporting) CIK: 0001454240 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-34186 | Film No.: 12972848